Understanding the molecular basis of agonist/antagonist mechanism of GPER1/GPR30 through structural and energetic analyses

被引:26
|
作者
Mendez-Luna, David [1 ]
Bello, Martiniano [1 ]
Correa-Basurto, Jose [1 ]
机构
[1] Inst Politecn Nacl, Lab Modelado Mol Bioinformat & Diseno Farm, Escuela Super Med, Plan de San Luis Y Diaz Miron S-N, Mexico City 11340, DF, Mexico
来源
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 2016年 / 158卷
关键词
GPER1; Molecular dynamics simulations; Docking; Principal Component Analysis; Ligand recognition; BETA(2) ADRENERGIC-RECEPTOR; PROTEIN-COUPLED RECEPTORS; A(2A) ADENOSINE RECEPTOR; ESTROGEN-RECEPTOR; CRYSTAL-STRUCTURE; SELECTIVE INTERACTION; LIGAND RECOGNITION; FREE-ENERGIES; DYNAMICS; DOCKING;
D O I
10.1016/j.jsbmb.2016.01.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The G-protein coupled receptors (GPCRs) represent the largest superfamily of membrane proteins in charge to pass the cell signaling after binding with their cognate ligands to the cell interior. In breast cancer, a GPCR named GPER1 plays a key role in the process of growth and the proliferation of cancer cells. In a previous study, theoretical methods were applied to construct a model of GPER1, which later was submitted to molecular dynamics (MD) simulations to perform a docking calculation. Based on this preceding work, it is known that GPER1 is sensitive to structural differences in its binding site. However, due to the nature of that past study, conformational changes linked to the ligand binding were not observed. Therefore, in this study, in order to explore the conformational changes coupled to the agonist/antagonist binding, MD simulations of about 0.25 mu s were performed for the free and bound states, summarizing 0.75 mu s of MD simulation in total. For the bound states, one agonist (G-1) and antagonist (G-15) were chosen since is widely known that these two molecules cause an impact on GPER1 mobility. Based on the conformational ensemble generated through MD simulations, we found that despite G-1 and G-15 being stabilized by similar map of residues, the structural differences between both ligands impact the hydrogen bond pattern not only at the GPER1 binding site but also along the seven-helix bundle, causing significant differences in the conformational mobility along the extracellular and cytoplasmic domain, and to a lesser degree in the curvatures of helix 2, helix 3 and helix 7 between the free and bound states, which is in agreement with reported literature, and might be linked to microscopic characteristics of the activated-inactivated transition. Furthermore, binding free energy calculations using the MM/GBSA method for the bound states, followed by an alanine scanning analysis allowed us to identify some important residues for the complex stabilization. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:104 / 116
页数:13
相关论文
共 34 条
  • [1] GPR30/GPER1: searching for a role in estrogen physiology
    Olde, Bjorn
    Leeb-Lundberg, L. M. Fredrik
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2009, 20 (08): : 409 - 416
  • [2] A Novel Mechanism of S-equol Action in Neurons and Astrocytes: The Possible Involvement of GPR30/GPER1
    Ariyani, Winda
    Miyazaki, Wataru
    Koibuchi, Noriyuki
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (20)
  • [3] GPER1/GPR30 in the brain: Crosstalk with classical estrogen receptors and implications for behavior
    Hadjimarkou, Maria M.
    Vasudevan, Nandini
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2018, 176 : 57 - 64
  • [4] Role of estrogen receptors alpha, beta and GPER1/GPR30 in pancreatic beta-cells
    Nadal, Angel
    Alonso-Magdalena, Paloma
    Soriano, Sergi
    Ripoll, Cristina
    Fuentes, Esther
    Quesada, Ivan
    Belen Ropero, Ana
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2011, 16 : 251 - 260
  • [5] The role of (xeno)estrogens and GPER1/GPR30 receptor for centrosome amplification and chromosomal instability in vitro
    Buehler, M.
    Schoenfelder, G.
    Schneider, M. R.
    Stolz-Ertych, A.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2021, 394 (SUPPL 1) : S21 - S22
  • [6] The role of (xeno)estrogens and GPER1/GPR30 receptor for centrosome amplification and chromosomal instability in vitro
    Fahrlaender, J.
    Stolz-Ertych, A.
    Schoenfelder, G.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2023, 396 : S46 - S46
  • [7] Elevated expression of GPR30/GPER1 is associated with poor prognosis in patients with uterine cervical adenocarcinoma.
    Takasawa, Akira
    Akimoto, Taishi
    Takasawa, Kumi
    Kyuno, Daisuke
    Osanai, Makoto
    CANCER SCIENCE, 2022, 113 : 1178 - 1178
  • [8] Raloxifene decreases cell viability and migratory potential in prostate cancer cells (LNCaP) with GPR30/GPER1 involvement
    Salata, Giovanna Cassone
    Pinho, Cristiane Figueiredo
    de Freitas, Andre T. A. G.
    Aquino, Ariana Musa
    Justulin, Luis Antonio
    Mendes, Leonardo Oliveira
    Goncalves, Bianca F.
    Delella, Flavia Karina
    Scarano, Wellerson Rodrigo
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2019, 71 (07) : 1065 - 1071
  • [9] G protein-coupled oestrogen receptor 1 (GPER1)/GPR30: a new player in cardiovascular and metabolic oestrogenic signalling
    Nilsson, Bengt-Olof
    Olde, Bjorn
    Leeb-Lundberg, L. M. Fredrik
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (06) : 1131 - 1139
  • [10] GPCR-mediated rapid, non-genomic actions of steroids: Comparisons between DmDopEcR and GPER1 (GPR30)
    Evans, Peter D.
    Bayliss, Asha
    Reale, Vincenzina
    GENERAL AND COMPARATIVE ENDOCRINOLOGY, 2014, 195 : 157 - 163